戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 while 11 proteins were identified in the NPM immunocomplex.
2 REST, and the proteins are found in the same immunocomplex.
3 e phosphorylated on tyrosine residues by the immunocomplex.
4 d secondary antibody to form a sandwich-type immunocomplex.
5 ted onto the immunonanobeads thus forming an immunocomplex.
6 crossing, the interaction yields immobilized immunocomplex.
7 the interaction yields a zone of immobilized immunocomplex.
8 nfirmed by immunoblotting of hBVR.PKC betaII immunocomplex.
9 ntibody (p53(392)d-Ab) to form sandwich-like immunocomplexes.
10 ometry that RAD50 protein is present in TRF2 immunocomplexes.
11 rs (Fc epsilon RIIb or CD23) by IgE-allergen immunocomplexes.
12 he CDK inhibitor p21Cip1 present in cyclin E immunocomplexes.
13 ed by its sequestration into visible MAP4-Ab immunocomplexes.
14  modulated by the formation of sandwich-like immunocomplexes.
15 ent protein kinase activity observed for ATM immunocomplexes, along with the association of ATM with
16 ion enriched in nucleolar proteins, and this immunocomplex also includes p125, the catalytic subunit
17 inhibited Cdc25A activity in the Cdc25A-EGFR immunocomplex and consequently caused prolonged EGFR tyr
18 med mass spectrometric analysis of the NEIL2 immunocomplex and identified Y box-binding (YB-1) protei
19            HSP70 was also found in the WASF3 immunocomplex and inactivation of HSP70 results in desta
20      VBP1, VHL, and p97 coexist in the hMSH4 immunocomplex and regulate the polyubiquitination of hMS
21 e, we show that WASF3 is present in the HER2 immunocomplex and suppression of WASF3 function leads to
22               We showed that the size of the immunocomplex and the field strength are the critical fa
23 ng the subsequent magnetic separation of the immunocomplex and the measurement of chemiluminescent si
24 y recognize the formation of hapten-antibody immunocomplexes and can thus be used to develop phage an
25  on the unique combination of a generic anti-immunocomplex (anti-IC) single-chain fragment of antibod
26 g the technical challenges of producing anti-immunocomplex antibody.
27 , immobilized zones of fluorescently labeled immunocomplex are subjected to a buffer dilution and mon
28                                    Images of immunocomplexes are presented in the characteristic view
29 application of the noncompetitive phage anti-immunocomplex assay (PHAIA) by converting an existing co
30 o optimize the performance of the phage anti-immunocomplex assay (PHAIA) technology.
31 p a single-step sandwich-type noncompetitive immunocomplex assay.
32 s and can thus be used to develop phage anti-immunocomplex assays (PHAIA) for noncompetitive detectio
33                                          The immunocomplex between a membrane protein, beta2 adrenerg
34 receptor (EGFR) promoted the formation of an immunocomplex between PLCgamma and NMDAR subunits.
35 le noncompetitive sandwich-type format using immunocomplex binding phage-borne peptides to detect the
36                              Formation of an immunocomplex brings the chemiluminescent compound and t
37                               ROC1 and APC11 immunocomplexes can catalyze isopeptide ligations to for
38       Finally, as revealed by FLN spectra of immunocomplexed chromophores, pi-pi interactions, rather
39 uffer dilution, while measuring the decay in immunocomplex concentration.
40                          Individual sandwich immunocomplexes consisting of (1) an anti-PSA antibody i
41                    Furthermore, precipitated immunocomplexes contained T-antigen, NF2, and p53, sugge
42                         We confirm here that immunocomplexes containing a tagged version of Mec1 cata
43 red for Ci phosphorylation in vivo, and Cos2-immunocomplexes (Cos2IPs) phosphorylate Ci and contain P
44 y REST to neuronal genes, is present in REST immunocomplexes, dephosphorylates S861/864, and stabiliz
45 ine and parenchymal organs or resulting from immunocomplex deposition due to B cell hyperactivity wit
46 to the known effects of other surfactants in immunocomplex dissociation or in maintenance of colloida
47 ive immunoassays to develop a new Phage Anti-Immunocomplex Electrochemical Immunosensor (PhAIEI) for
48 tein, under optimized condition, forming the immunocomplex FITC-PrA-Ab-PrP.
49        With the aid of a running buffer, the immunocomplexes flow and reach the immuno-conjugated ele
50 tive glomerulonephritis due to deposition of immunocomplexes followed by cardiomegaly with ventricula
51                   To quantify kon, we assess immunocomplex formation for a range of antigen-antibody
52 anning results in a very high probability of immunocomplex formation for very low Ag concentrations,
53                      The successful sandwich immunocomplex formation is then recorded electrochemical
54                  The dose-response curve for immunocomplex formation of TNT on the scFv-functionalize
55 ic peak current in anionic redox probe after immunocomplex formation with antibodies was used for PSA
56 ciple of photoluminescence quenching of upon immunocomplex formation with antibody-functionalized dia
57 orescent phosphopeptide used as a tracer for immunocomplex formation with phosphotyrosine antibody.
58 nnels (20 nm pore sized) blockage due to the immunocomplex formation.
59 kon is quantified by assessing the amount of immunocomplex formed at each interaction time.
60 now shows that HSP90 is present in the WASF3 immunocomplex from prostate cancer cells.
61 o uses a handoff mechanism that switches the immunocomplex from the stacking mode to the separation m
62                                        NEIL2 immunocomplexes from cell extracts preferentially repair
63 hotyrosine and anti-c-Src immunoprecipitated immunocomplexes from heated cells.
64                                 In contrast, immunocomplexes from inaC mutants missing eye-PKC, displ
65 continuously separating the antibody-protein immunocomplexes from the unbound antibodies, utilizing t
66 imultaneously differentiate between free and immunocomplexed haptens.
67                        The IL-2/anti-IL-2 Ab immunocomplex has recently been shown to expand the natu
68  association of p65 with biologically active immunocomplex-histone acetyltransferase assay was depend
69                                 Furthermore, immunocomplex-histone acetyltransferase assays demonstra
70                          Preformed B2C5-UvrB immunocomplexes, however, inhibited formation of those i
71 r wall of the column, forming the "sandwich" immunocomplexes (immobilized antibody-E. coli O157: H7-e
72 I kappa B alpha can be catalyzed by the ROC1 immunocomplex in vitro.
73  show that the electrophoretic separation of immunocomplexes in free solution can be readily accompli
74 is a more efficient substrate for IKKepsilon immunocomplexes in human FLS and this activity appears t
75                  Two-dimensional averages of immunocomplexes in which the ryanodine receptor was in t
76                                    Wild-type immunocomplexes incubated with [(32)P]ATP revealed phosp
77 c subunit was identified in endogenous FOXO1 immunocomplexes, indicating that PP2A is a FOXO1 phospha
78     To quantify koff, an immobilized zone of immunocomplex is subjected to in situ buffer dilution, w
79                FEN-1 is present in the NEIL1 immunocomplex isolated from human cell extracts, and the
80  it was absent in the LP-BER-proficient APE1 immunocomplex isolated from the mitochondrial extract th
81                Incubation of anti-PLC-gamma1 immunocomplexes isolated from rat brain with recombinant
82 ities were determined by immunochemistry and immunocomplex kinase assay approaches.
83                        Furthermore, in vitro immunocomplex kinase assay with Akt1, a natural substrat
84 f NF-kappaB kinase (IkappaB), as examined by immunocomplex kinase assay, IkappaB phosphorylation, and
85 KC(epsilon) knockout mice and in vitro in an immunocomplex kinase assay, PKC(epsilon) phosphorylated
86                      Unlike the conventional immunocomplex kinase assay, this assay directly utilizes
87   Protein kinase activities were measured by immunocomplex kinase assay.
88                                              Immunocomplex kinase assays demonstrated an IL-1-activat
89                                              Immunocomplex kinase assays with cyclin-dependent kinase
90 ed member-specific antibodies, and performed immunocomplex kinase assays with extracts from elicited
91 scence method, MAPK activity was measured by immunocomplex kinase assays, and Western blot analysis a
92 rmore, incubation of activated ERK2 with FAK immunocomplexes leads to FAK phosphorylation at Ser-910
93                      The assay is a sandwich immunocomplex microarray that functions via excitation b
94 the excited-state vibrational frequencies of immunocomplexed molecules allowing for unambiguous spect
95                                    Then, the immunocomplex of antihuman IgE Abs with the patient IgE
96 g a peptide that specifically recognizes the immunocomplex of atrazine with an anti-atrazine monoclon
97          p185HER2/Neu was also identified in immunocomplexes of c-Src following ligand activation of
98 ng an intact Y-box sequence in CFTR; 6) that immunocomplexes of CDP/cut possess an associated histone
99                                          The immunocomplexes of RIP140 from cells transfected with RI
100 y measuring the formation of the fluorescent immunocomplex on the waveguide surface.
101 was dependent on the formation of sandwiched immunocomplexes on the particles.
102                                   The formed immunocomplexes on the test line can further be excised
103 ith specific antibodies and then labeled the immunocomplexes (one or zero labeled target protein mole
104 on of the benefits of integrating phage anti-immunocomplex particles into electrochemical immunosenso
105   In contrast, although present in the NEIL2 immunocomplex, PCNA does not stimulate NEIL2.
106 ein-multipeptide constructs composed of anti-immunocomplex peptides selected from phage libraries and
107 enerated recombinant chimeras by fusing anti-immunocomplex peptides selected from phage libraries to
108 s a scaffold for multivalent display of anti-immunocomplex peptides.
109 to 3-phenoxybenzoic acid (3-PBA) and an anti-immunocomplex phage clone bearing the cyclic peptide CFN
110       Substrate trapping in intact cells and immunocomplex phosphatse assays confirmed that alpha-cat
111  during SM22 gene expression and SRF and CBP immunocomplexes possess HAT activities in smooth muscle
112                                   The mSin3A immunocomplexes possess histone deacetylase activity tha
113                          This Ets-1-CBP/p300 immunocomplex possessed histone acetyltransferase activi
114  assays of kinase activity were performed in immunocomplexes precipitated by an antibody against the
115 to the preconcentration step to separate the immunocomplex products formed.
116  protein were inhibited both in vitro and in immunocomplexes purified from the cell extracts.
117  both Eps8 and TLR4 were present in the same immunocomplex regardless of LPS stimulation.
118  molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constit
119 rticles and antigen was captured, the formed immunocomplex resulted in a decrease of the darkness and
120               Electron microscopic images of immunocomplexes show two antibody binding sites.
121 eaching the test line, where a sandwich-like immunocomplex takes place due to the presence of antibod
122 roduced to the sensing system, forming large immunocomplexes that prevent CL substrate access to the
123 that administration of the IL-2/anti-IL-2 Ab immunocomplex to C57BL/6 mice, prior to corneal HSV-1 in
124 itiated by the addition of a PiaA-associated immunocomplex to membranes of TORC2-deficient cells and
125                         The kinase activity (immunocomplex toward S6 peptide) of each isoform was act
126 rmined on days 7 and 16 postinfection in the immunocomplex-treated group of infected mice.
127 rease in NK cell numbers in corneas from the immunocomplex-treated group of mice.
128 eas from the control group, corneas from the immunocomplex-treated group showed a significant reducti
129                                              Immunocomplex treatment given on days 5, 6, and 7 postin
130 roteins were identified as unique to the ALK immunocomplex using monoclonal and polyclonal antibodies
131                                          The immunocomplex was performed by using tosylactivated magn
132 eak current of Fe(CN)6(3-)/Fe(CN)6(4-) after immunocomplexed was formed.
133     The activity of p85/p110beta (PI3-Kbeta) immunocomplexes was elevated by increase[Ca2+]e and acti
134 ies and a mass spectroscopic analysis of the immunocomplex, we show the presence of homo- and heterom
135 hat recognize the BDE 47-polyclonal antibody immunocomplex were isolated.
136 s detected from the C-Dots on these sandwich immunocomplexes were positively correlated to the concen
137                                              Immunocomplex Western blotting demonstrated increased as
138 gh the shallow regions easier than the large immunocomplex, when the flow-field is applied in an obli
139 ced by a tyrosine kinase associated with the immunocomplexes, whereas in vitro phosphorylation of rec
140  allowed to interact with each other to form immunocomplexes which are then typically captured by pro
141 specifically react with the analyte-antibody immunocomplex, which allows the detection of these small
142 ity associated with cdk4, cyclin E, and cdk2 immunocomplexes, which normally increases following seru
143 kinase (CDK) inhibitor, p27Kip1, to cyclin E immunocomplexes, which resulted in a reduction in CDK2 k
144 inding to bax since less bax was observed in immunocomplex with bcl-2 in taxol-treated cancer cells.
145 ese transcription factors are present in the immunocomplex with purified p53, implicating modificatio
146 Dot-labeled Ab2 was added to form a sandwich immunocomplex with the AFP bound to the Ab1-coated wells
147                                     erbB2 is immunocomplexed with a GPCR in vivo and is transactivate
148        The phosphorylated peptide product is immunocomplexed with the anti-phosphotyrosine antibody r
149 ells, the C/EBPdelta protein was detected in immunocomplexes with both Rb and E2F1.
150   Finally, we found that Galpha(q/11) formed immunocomplexes with the type-A endothelin receptor and

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top